Difference between revisions of "CD10"
Jump to navigation
Jump to search
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[File:Kidney cd10 ihc.jpg|thumb|right|250px|CD10 staining in normal [[kidney]].]] | |||
'''CD10''' is a commonly used [[immunostain]]. | '''CD10''' is a commonly used [[immunostain]]. | ||
==Positive== | ==Positive== | ||
===Benign=== | |||
*Benign liver.<ref name=pmid14755758/> | *Benign liver.<ref name=pmid14755758/> | ||
*[[ | *[[Endometriosis]] - stains the stroma.<ref name=Ref_DCHH236>{{Ref DCHH|236}}</ref> | ||
===Lymphoma=== | ===Lymphoma=== | ||
*[[Follicular lymphoma]]. | *[[Follicular lymphoma]]. | ||
*[[Diffuse large B-cell lymphoma]]. | *[[Diffuse large B-cell lymphoma]]. | ||
===Other tumours=== | |||
*[[Clear cell renal cell carcinoma]]. | |||
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref> | |||
*[[Endometrial stromal sarcoma]]. | |||
*[[Solid pseudopapillary tumour]]. | |||
==Variable== | |||
*Tumours of [[adrenal gland]].<ref name=pmid20390424>{{Cite journal | last1 = Mete | first1 = O. | last2 = Kapran | first2 = Y. | last3 = Güllüoğlu | first3 = MG. | last4 = Kiliçaslan | first4 = I. | last5 = Erbil | first5 = Y. | last6 = Senyürek | first6 = YG. | last7 = Dizdaroğlu | first7 = F. | title = Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas. | journal = Virchows Arch | volume = 456 | issue = 5 | pages = 515-21 | month = May | year = 2010 | doi = 10.1007/s00428-010-0901-0 | PMID = 20390424 }}</ref> | |||
==Negative== | |||
*[[Clear cell papillary renal cell carcinoma]]. | |||
==See also== | ==See also== | ||
Revision as of 15:52, 9 August 2016
CD10 staining in normal kidney.
CD10 is a commonly used immunostain.
Positive
Benign
- Benign liver.[1]
- Endometriosis - stains the stroma.[2]
Lymphoma
Other tumours
- Clear cell renal cell carcinoma.
- Hepatocellular carcinoma.[1]
- Endometrial stromal sarcoma.
- Solid pseudopapillary tumour.
Variable
- Tumours of adrenal gland.[3]
Negative
See also
References
- ↑ 1.0 1.1 Lin, F.; Abdallah, H.; Meschter, S. (Feb 2004). "Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.". Diagn Cytopathol 30 (2): 92-7. doi:10.1002/dc.10419. PMID 14755758.
- ↑ Tadrous, Paul.J. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum (1st ed.). Wiley. pp. 236. ISBN 978-0470519035.
- ↑ Mete, O.; Kapran, Y.; Güllüoğlu, MG.; Kiliçaslan, I.; Erbil, Y.; Senyürek, YG.; Dizdaroğlu, F. (May 2010). "Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas.". Virchows Arch 456 (5): 515-21. doi:10.1007/s00428-010-0901-0. PMID 20390424.